Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04039490 · ClinicalTrials.gov registry record · NA
Novel Device for Ultrasound-guided Pediatric Vessel Cannulations
A NA study of Clinical Procedures Which Require Vessel Cannulations in Pediatric Patients, sponsored by Clear Guide Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT04039490: Recruiting NA study of Clinical Procedures Which Require Vessel Cannulations in Pediatric Patients, sponsored by Clear Guide Medical.
NCT04039490 is a NA study of Clinical Procedures Which Require Vessel Cannulations in Pediatric Patients that is actively recruiting participants, run by Clear Guide Medical. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04039490, a NA study of Clinical Procedures Which Require Vessel Cannulations in Pediatric Patients, is actively recruiting participants, sponsored by Clear Guide Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Clinical Trial to investigate whether the use of a novel device to be used in conjunction with ultrasound in pediatric vessel cannulations is superior to ultrasound-only pediatric vessel cannulations in terms of number of cannulation attempts.
Primary Outcome
Test if the vessel cannulation was successful with only 1 attempt --needle puncture--to reach the vessel
Conditions Studied
Interventions
- DEVICE SCENERGY
Study Locations (1)
District of Columbia
- Children's National Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-02-06 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
What NCT04039490 shows while recruiting
NCT04039490 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Clinical Procedures Which Require Vessel Cannulations in Pediatric Patients appearing as the primary indexed condition, and to 1 intervention - of which SCENERGY is the first listed.
NCT04039490 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04039490 about?
NCT04039490 is a clinical study titled "Novel Device for Ultrasound-guided Pediatric Vessel Cannulations". Clinical Trial to investigate whether the use of a novel device to be used in conjunction with ultrasound in pediatric vessel cannulations is superior to ultrasound-only pediatric vessel cannulations in terms of number of cannulation attempts.
What is the current status of trial NCT04039490?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-02-06. Estimated completion is 2025-08-31.
What conditions does trial NCT04039490 study?
This clinical trial studies the following conditions: Clinical Procedures Which Require Vessel Cannulations in Pediatric Patients.
What interventions are being tested in trial NCT04039490?
The interventions under investigation include: SCENERGY (DEVICE).
Who is sponsoring clinical trial NCT04039490?
This trial is sponsored by Clear Guide Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04039490 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04039490's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI